Macro Helix

Macro Helix is a leading provider of 340B Drug Pricing Program management software and services for hospitals, health systems, and retail pharmacies. Its flagship platform, 340B Architect, helps covered entities manage split billing, maintain regulatory compliance, and optimize pharmacy spend. The company also offers solutions for contract pharmacy administration, patient assistance programs, and data analytics to improve financial performance and patient access to affordable medications. Acquired by McKesson in 2012, Macro Helix operates as a key component of McKesson's pharmacy technology portfolio. The company serves over 1,000 covered entities, representing approximately 40% of 340B-eligible hospitals in the United States. Its technology is designed to simplify the operational and regulatory complexities of the federal discount drug program.